Anti-dementia medications | Alzheimer's Society

What can help mixed feelings over news about the latest Alzheimer’s medications?

Advice on dealing with ‘wonder drug’ headlines about lecanemab and donanemab.

Complaint upheld against advertising of NeuroAD as Alzheimer’s disease treatment

The Advertising Standards Agency (ASA) have upheld a complaint made against Neuronix for their advertising of a medical device in relation to Alzheimer's disease.

Carers' tips: Sudden changes

01 February 2018

Pfizer ends neuroscience discovery programme, including research into Alzheimer’s disease treatment – Alzheimer’s Society comment

Pfizer has announced that it will be ending its neuroscience discovery and early development efforts, an area which includes research into drug development for Alzheimer’s disease.